EU Cybersecurity Label Risks Unfair Bias Against Big Techby Lilu Anderson 17.06.2024EU Commission, ENISA, and EU nations to discuss the evolving EUCS scheme, aimed at ensuring secure cloud vendors amid industry ...
India’s Cybersecurity Faces Policy Gaps, Skilled Worker Shortageby Lilu Anderson 17.06.2024Many sectors lack robust cyber defenses; India faces APT groups & hacktivists. Enhancing global partnerships is key to counter cross-border ...
CDS Analytical Licenses UD’s Game-Changing Proteomics Techby Lilu Anderson 16.06.2024E3technology enhances Empore™ membranes for better proteome sample prep, crucial for low-cell proteomics, say experts at UD and CDS Analytical.
BlockDAG X1 Beta App: Game-Changer in Crypto Mining?by John Darbie 16.06.2024BlockDAG's X1 mobile mining app launches amid Ethereum vs. Solana supremacy battle; XRP lags peers. Invest in BlockDAG presale.
NaaS Technology Hits 12-Month Low Amid Earnings Reportby Mark Eisenberg 16.06.2024NaaS Technology (NASDAQ:NAAS) posted Q1 losses with EPS at ($1.40). Laidlaw Wealth Management boosted stakes 242.8% in Q4.
BlockDAG X1 Beta App: Game-Changer in Crypto Mining?by John Darbie 16.06.2024BlockDAG's tool enhances mining efficiency; users can earn more by engaging or inviting others. Invest now: blockdag.network. Research and invest ...
New Investments in Child Care Crucial for Military Familiesby Mark Eisenberg 16.06.2024Local military families face a child care crisis, spending 26% of income. With only 750 slots on base, they rely ...
Roaring Kitty’s $262M in GameStop: Market Manipulation?by Mark Eisenberg 15.06.2024Exploring market manipulation and the evolving nature of meme stocks; questioning if Roaring Kitty has become the new Goliath amidst ...
Avidity Biosciences CFO Sells $3.7M in Stock Amid Positive Newsby Terry Bingman 15.06.2024Avidity Biosciences sees share ownership shift as MacLean reduces holding under Rule 10b5-1 Plan; positive sector developments bolster outlook.
Avidity Biosciences Director Sells $3.8M in Stockby Mark Eisenberg 15.06.2024Arthur A. Levin sells 40K Avidity shares; BofA ups target to $45 as FDA advances myotonic dystrophy treatment. AI-assisted article ...